Abstract
Diabetes mellitus is a generic name of a syndrome that is defined by a glucose value, however there are different types of diabetes with different pathogenesis, so the importance to define the type of diabetes in a newly diagnosed diabetic patient. Diabetes Mellitus (DM) is a syndrome characterized by hyperglycemia and impaired metabolism of carbohydrates, proteins and fats, due to an absolute or relative deficiency of the secretion and/or insulin action.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Vaccaro O, et al. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care. 1999;22:1490–3.
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2017;40(Supplement 1):s11–24.
National Institute for Health and Care Excellence. NICE guidance 2017, Type 2 diabetes in adults: management [NG28].
National Center for Biotechnology Information, U.S. National Library of Medicine Policies and Guidelines. Gene ID: 3119. HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 [Homo sapiens (human)], updated on 23 July 2017.
Bonifacio E. Predicting Type 1 diabetes using biomarkers. Diabetes Care. 2015;38(6):989–96.
Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473–9.
In’t Veld P. Insulitis in human type 1 diabetes. The quest for an elusive lesion. Islets. 2011;3(4):131–8. https://doi.org/10.4161/isl.3.4.15728.
Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. Br Med Bull. 2008;88(1):115–29. https://doi.org/10.1093/bmb/ldn045.
Pihoker C, Lernmark Å, et al. Autoantibodies in diabetes. Diabetes. 2005;54(suppl 2):S52–61.
Skyler J. Insulin therapy in type 1 diabetes mellitus. In: De Fronzo R, editor. Current therapy of diabetes mellitus. St. Louis, MO: Mosby; 1998. p. 36–49.
Poskus E, Ermácora M. Los avances en Diabetes Mellitus impulsados por los inmunobiológicos recombinantes. En Bioquímica y Patología Clínica. 1998;62(1):18–31.
Frechtel G, Poskus E. Diabetes autoinmune de inicio en edad infanto-juvenil y adulta. Bases racionales para el diagnóstico y tratamiento. Separata; Lugar: Buenos Aires; 2005.
Caputo M, Cerrone GE, López AP, González C, Mazza C, Cédola N, Puchulu FM, Targovnik HM, Frechtel GD. Genotipificación del gen HLA DQB1 en diabetes autoinmune del adulto (LADA). Medicina. 2005;65:235–40.
Poskus E. Autoinmunidad, marcadores inmunológicos en diabetes mellitus. En Diabetes mellitus. Tercera Edición. Ruiz M. Editorial; 2004. p. 20–55.
Valdez SN, Iacono RF, Villalba A, Cardoso Landaburu A, Ermácora M, Poskus E. A radioligando-binding assay for detecting antibodies specific for proinsulin and insulin using 355-proinsulin. J Immunol Methods. 2003;279:173–81.
De Grijse J, Asanghanwa M, Nouthe B, et al. Belgian diabetes registry. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to selectfirst-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia. 2010;53:517–24.
Wenzlau JM, Moua O, Sarkar SA, Yu L, Rewers M, Eisenbarth GS, et al. SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes. Ann N Y Acad Sci. 2008;1150:256–9.
Yang L, Luo S, Huang G, Peng J, Li X, Yan X, et al. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev. 2010;26:579–84.
Kawasaki E. ZnT8 and type 1 diabetes. Endocr J. 2012;59(7):531–7. Epub 2012 Mar 8.
Verge GF, et al. Prediction of type 1 diabetes mellitus in first-degree relatives using a combination of insulin, GAD and ICA512/IA-2 autoantibodies. Diabetes. 1996;45:926–33.
Reaven GM. Insulin resistance-how important is it to treat? Exp Clin Endocrinol Diabetes. 2000;108(Suppl 2):S274–80.
Recomendaciones para gestantes con diabetes. Conclusiones del Consenso reunido por convocatoria del Comité de Diabetes y Embarazo de la SAD. Octubre 2008.
Ross G. Gestational diabetes. Aust Fam Physician. 2006;35(6):392–6.
American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2016;39(suppl 1):S1–S106.
Attiya K, Sahar F. Maturity-onset diabetes of the young (MODY) genes: literature review. Clin Pract. 2012;1(1):4–11.
Kahn S, Cooper M, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present and future. Lancet. 2014;383(9922):1068–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Puchulu, F.M. (2018). Definition, Diagnosis and Classification of Diabetes Mellitus. In: Cohen Sabban, E., Puchulu, F., Cusi, K. (eds) Dermatology and Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-72475-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-72475-1_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72474-4
Online ISBN: 978-3-319-72475-1
eBook Packages: MedicineMedicine (R0)